Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Nanovesicles from Adipose Derived Stem Cells Delay Hair Follicle Degeneration and Stimulate Regeneration: a Novel Therapeutic Strategy for Androgenetic Alopecia.

Tang S., Wu X., Wang Y., Zhang W., Wang J., Zhang J.

Animal Study on Hair Loss, Hair Regeneration, published in Stem Cell Rev Rep (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Stem Cell Rev Rep (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40773049
DOI
10.1007/s12015-025-10953-1

Abstract (original English)

Background Androgenetic alopecia has emerged as a significant medical and social concern. Current therapeutic options are limited, necessitating the exploration of more effective treatments. This study aimed to evaluate the efficacy of adipose derived stem cells nanovesicles (ADSC-NV) in treating androgenetic alopecia. Results ADSC-NV presented as biconcave disc-shaped entities, with a mean diameter of 87.3 ± 36.5 nm. Nanovesicles significantly promoted the proliferation and migration of DPC, with a concentration of 60µg/mL demonstrating superior efficacy compared to 30 µg/mL. Besides, nanovesicles were found to slow the degeneration of hair follicles in androgenetic alopecia during in vitro culture. Intradermal injection of nanovesicles markedly enhanced hair regeneration in the dorsal skin of mice in vivo. Histological examination revealed that nanovesicles reversed hair follicle miniaturization and accelerated the transition of hair follicles from the telogen phase to the anagen phase. Notably, nanovesicles achieved an effect comparable to minoxidil, while also reducing sebum secretion. Conclusion This study demonstrated the therapeutic potential of ADSC-NV in treating androgenetic alopecia both in vitro and in vivo. This finding provides a promising therapeutic strategy for addressing androgenetic alopecia.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AlopeciaHair FollicleAnimalsRegenerationMiceStem CellsCell ProliferationAdipose TissueMaleHumans

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research